DataString Consulting Company Logo
DataString Consulting Company Logo
Transcatheter Asd Occluder Market
Home»Recent Reports»Transcatheter Asd Occluder Market

Transcatheter Asd Occluder Market

Author: Debadatta Patel - Senior Consultant, Report ID - DS1801183, Published - June 2025

Segmented in Product Type (Balloon Expandable, Self-Expandable, Hybrid), End-use Industries (Hospitals, Cardiac Centers, Ambulatory Surgical Centers, Others), Technology, Patient Age, Manufacture Method and Regions - Global Industry Analysis, Size, Share, Trends, and Forecast 2024 – 2034

Share this report:

Global Transcatheter Asd Occluder
Market Outlook

The market, for Transcatheter Asd Occluder was estimated at $524.9 million in 2024; and it is anticipated to increase to $819.2 million by 2030 with projections indicating a growth to around $1.2 billion by 2035. This expansion represents a compound annual growth rate (CAGR) of 7.7% over the forecast period. The data mentioned above highlights the growth indicators associated with the Transcatheter ASD Occluder market and showcases its importance and potential in the healthcare industry convincingly. The key factors driving this trend encompass advancements in procedures surging demand for minimally invasive surgeries and the escalating incidence of Atrial Septal Defect cases worldwide. In addition to these points the increased emphasis, on well being and comfort cost efficiency and the push to shorten hospital stays further cement the crucial role and continuing relevance of the Transcatheter ASD Occluder.


The focal point of this growth trend lies in the Transcatheter ASD Occluder—a medical tool crafted for closing an ASD without the need for surgery. Known for its properties and minimally invasive nature it enables a speedier healing process while reducing the risks of post operative issues. The devices ease of use and safety measures have significantly contributed to its acceptance, in treating ASD, especially among children and older adults.


Market Size Forecast & Key Insights

2019
$524M2024
2029
$1.1B2034

Absolute Growth Opportunity = $577M

The Transcatheter Asd Occluder market is projected to grow from $524.9 million in 2024 to $1.10 billion in 2034. This represents a CAGR of 7.7%, reflecting rising demand across Pediatric Cardiology, Emergency Medicine and Adult Cardiovascular Care.

The Transcatheter Asd Occluder market is set to add $577 million between 2024 and 2034, with manufacturer targeting Cardiac Centers & Ambulatory Surgical Centers End-use Industries projected to gain a larger market share.

With Increased prevalence of atrial septal defects, and Technological advancements in minimally invasive procedures, Transcatheter Asd Occluder market to expand 110% between 2024 and 2034.

Opportunities in the Transcatheter Asd Occluder Market

Growth Prospects in Developing Economies

In developing nations that make up a large part of the worlds population growth today there is a growing demand for advanced medical treatments such, as the Transcatheter ASD Occluder device.

Technological Advancements and Adoption and Strategic Collaborations for Market Penetration

The progress in health technology has led to the development of devices such as the Transcatheter ASD Occluder providing a less invasive option for treating atrial septal defects . Manufacturers of these tools stand to benefit from the increasing focus on patient well being and quick recovery in the healthcare industry thanks, to the innovative design and biocompatibility features of ASD Occluders that are driving up their popularity.

When product manufacturers team up with practitioners or health organizations it can greatly enhance the uptake and approval of Transcatheter ASD Occluders in the healthcare field. By collaborating with cardiologists and other healthcare experts there is an opportunity to gain insights into how the product is used and its effectiveness, which can ultimately result in enhancements. Furthermore such partnerships can also boost the recognition and trustworthiness of the device among a group of patients.

Growth Opportunities in North America and Asia-Pacific

Asia Pacific Outlook

The Asia Pacific region is showing progress in the market for transcatheter ASD occluders due to the growing number of congenital heart diseases and a large population base driving this trend forward. The competition in this region is varied with international companies aiming to make their mark and local firms advancing device innovation and affordable options. Opportunities in this region focus, on creating cost transcatheter ASD occluders and improving healthcare facilities. In this region well a key factor is the increasing need, for less invasive methods to close ASDs. This mirrors the healthcare movement worldwide towards treatments that prioritize patient well being and swift healing.

North America Outlook

The market for ASD occluders in North America is seeing a notable rise thanks to advancements in these devices and the growing number of Atrial Septal Defect cases being reported there. Major players with product offerings are contributing to this growth trend in the regions competitive market landscape. Competition is fierce among both known and up and coming companies competing in this space. Exciting opportunities lie in advancing technology for invasive closure procedures, for ASD and developing occluders tailored to individual patients needs. Focusing on detecting and treating heart defects also highlights potential growth opportunities, in the market.

North America Outlook

The market for ASD occluders in North America is seeing a notable rise thanks to advancements in these devices and the growing number of Atrial Septal Defect cases being reported there. Major players with product offerings are contributing to this growth trend in the regions competitive market landscape. Competition is fierce among both known and up and coming companies competing in this space. Exciting opportunities lie in advancing technology for invasive closure procedures, for ASD and developing occluders tailored to individual patients needs. Focusing on detecting and treating heart defects also highlights potential growth opportunities, in the market.

Asia-Pacific Outlook

The Asia Pacific region is showing progress in the market for transcatheter ASD occluders due to the growing number of congenital heart diseases and a large population base driving this trend forward. The competition in this region is varied with international companies aiming to make their mark and local firms advancing device innovation and affordable options. Opportunities in this region focus, on creating cost transcatheter ASD occluders and improving healthcare facilities. In this region well a key factor is the increasing need, for less invasive methods to close ASDs. This mirrors the healthcare movement worldwide towards treatments that prioritize patient well being and swift healing.

Growth Opportunities in North America and Asia-Pacific

Established and Emerging Market's Growth Trend 2025–2034

1

Major Markets : U.S., Germany, China, Japan, Australia are expected to grow at 5.0% to 7.4% CAGR

2

Emerging Markets : Brazil, Indonesia, South Africa are expected to grow at 8.9% to 10.6% CAGR

Market Analysis Chart

The interactions within the Transcatheter ASD Occluderindustry'smarket dynamics are intriguing as they involve factors influencing its growth and limitations significantly. One key factor boosting the market for ASD Occluder devices is the growing occurrence of Atrial Septal Defects that these specialized medical instruments effectively address. With the enhancement of health awareness the identification of ASD as a significant heart anomaly has led to a higher adoption of these occluders, on a worldwide scale.

Recent Developments and Technological Advancement

December 2024

Medtronic revealed a version of the Transcatheter ASD Occluder that offers improved patient suitability and a lower risk of complications.

November 2024

St Jude Medical has expanded its reach with the introduction of their innovative Transcatheter ASD Occluder, which utilizes state of the art bioabsorbable technology.

August 2024

Boston Scientific Corporation achieved a milestone worldwide in the Transcatheter ASD Occluder sector with its innovative product that offers shorter surgery duration and improved overall patient outcomes in the long run.

In the advancements in the Transcatheter ASD Occluder sector show notable expansion and creativity within the field. Primarily driven by the need for invasive treatments, for atrial septal defects the Transcatheter ASD Occluder stands out as a leading edge medical device.

Impact of Industry Transitions on the Transcatheter Asd Occluder Market

As a core segment of the Medical Device industry, the Transcatheter Asd Occluder market develops in line with broader industry shifts. Over recent years, transitions such as Emergence of Dynamic Imaging Technologies and Rise of Bioabsorbable Occluders have redefined priorities across the Medical Device sector, influencing how the Transcatheter Asd Occluder market evolves in terms of demand, applications and competitive dynamics. These transitions highlight the structural changes shaping long-term growth opportunities.

1

Emergence of Dynamic Imaging Technologies:

The landscape of Transcatheter ASD Occluder market has seen a shift due to the introduction of advanced imaging tools that enable more accurate closure of atrial septal defects. Companies in the medical device sector are now incorporating these technologies into their Transcatheter ASD Occluders to improve their features and attract a range of customers. This evolution has also influenced sectors, in healthcare leading to better patient satisfaction and enhanced surgical results.

2

Rise of Bioabsorbable Occluders:

The adoption of occluders marks a significant advancement, in the field of Transcatheter ASD Occluders. Its purpose is to facilitate the natural healing process of the defect without requiring a permanent implant. Bioabsorbable materials have not only enhanced patient comfort but also reduced the risks linked to prolonged implantation procedures.

Global Events Shaping Future Growth

The chart below highlights how external events including emerging market developments, regulatory changes, and technological disruptions, have added another layer of complexity to the Medical Device industry. These events have disrupted supply networks, changed consumption behavior, and reshaped growth patterns. Together with structural industry transitions, they demonstrate how changes within the Medical Device industry cascade into the Transcatheter Asd Occluder market, setting the stage for its future growth trajectory.

Market Dynamics and Supply Chain

Driver: Increased Prevalence of Atrial Septal Defects, and Growing Healthcare Infrastructure and Accessibility

The increasing occurrence of ASD instances among the populace presents a notable opportunity for the Transcatheter ASD Occluder in the market sector. The rise in ASD cases due to factors and lifestyle choices is also driving the need for efficient and minimally invasive treatment alternatives such as the Transcatheter ASD Occluder. This has also led to its popularity, among healthcare providers as a preferred treatment option.
Improvements in the healthcare system and initiatives to enhance the availability of services in developing regions are also driving a rise in the use of advanced treatments for heart conditions. The popularity of the Transcatheter ASD Occluder is also increasing thanks to its qualities and advantages as more treatment facilities with state of the art medical equipment become accessible. This trend is also playing a role, in boosting the market expansion for this advanced cardiac intervention tool.
The healthcare industry is also embracing techniques that involve less invasive procedures like the Transcatheter ASD Occluder to improve patient outcomes and speed up recovery times while reducing infection risks This progress is also driving growth in medical device businesses and leading to a shift, towards more minimally invasive heart surgeries.

Restraint: High Installation Costs

The Transcatheter ASD Occluder has brought about an era in treating atrial septal defects with its innovative minimally invasive approach; however. One major challenge hindering its adoption is the high costs associated with installation. In healthcare facilities worldwide. Especially those, in developing countries. The significant financial commitment needed to purchase and upkeep this cutting edge technology poses an obstacle. This not only hampers its reach in the market but also influences consumer choices as cost conscious individuals might prefer traditional surgical options instead.

Challenge: Lack of Skilled Professionals

One other important factor is the shortage of experts who are proficient in using the Transcatheter ASD Occluder device effectively. This innovative technology requires a level of technical knowledge and operational comprehension that may not only be easily accessible in all healthcare settings. This insufficiency creates a hurdle, for meeting market needs since it might result in usage of the product and consequently slower expansion of the market.

Supply Chain Landscape

Raw Material Suppliers

Johnson & Johnson

Bayer AG

Component Manufacturers

Medtronic

Abbott Laboratories

Assembly & Testing
Boston Scientific Corporation / St. Jude Medical
Distribution & Retail
Cardinal Health / McKesson Corporation
Raw Material Suppliers

Johnson & Johnson

Bayer AG

Component Manufacturers

Medtronic

Abbott Laboratories

Assembly & Testing

Boston Scientific Corporation

St. Jude Medical

Distribution & Retail

Cardinal Health

McKesson Corporation

Banner LogoBanner Logo

Leading Providers and Their Strategies

Application AreaIndustryLeading Providers / ConsumersProvider Strategies
Heart Ailment Diagnostics
Medical Devices Industry
Biotronik
Product Innovation and Partnerships with medical establishments for trials and testing
Cardiac Surgery
Healthcare Service Industry
Abbott Laboratories
Strategic partnerships, expansion of product portfolio, continued Research and Development
Pediatric Cardiology
Pediatric Healthcare Industry
MicroPort Scientific Corporation
Focusing on extensive Research and Development, Adoption of advanced manufacturing technologies
Adult Congenital Heart Disease Treatment
Healthcare Industry
Lifetech Scientific
Expansion of global presence, Development of novel and advanced products

Elevate your strategic vision with in-depth analysis of key applications, leading market players, and their strategies. The report analyzes industry leaders' views and statements on the Transcatheter Asd Occluder market's present and future growth.

Our research is created following strict editorial standards. See our Editorial Policy

Applications of Transcatheter Asd Occluder in Emergency Medicine, Adult Cardiovascular Care and Pediatric Cardiology

Emergency Medicine

In emergency situations the use of Transcatheter ASD Occluders is vital in the field of emergency medicine as they provide an effective option instead of surgery to stabilize patients with a serious ASD condition. Abbott Laboratories is a player in this region, for creating trustworthy and user friendly occluders that improve patient results during emergencies.

Adult Cardiovascular Care

In the field of adult heart health treatment there is a growing use of Transcatheter ASD Occluders. This invasive approach is especially advantageous for older individuals as it carries fewer risks than the conventional open heart surgery method. Market leaders such as companies like W. L Gore & Associates and Boston Scientific are at the forefront in this region due, to their occluders that offer low complication rates and impressive long term outcomes.

Pediatric Cardiology

Pediatric cardiology often relies heavily upon Transcatheter ASD Occluders as a treatment option for young patients diagnosed with Atrial Septal Defects . These devices are preferred in cases for their minimally invasive nature and their ability to effectively close the defect without causing significant discomfort or post operative pain to the patients experience is less invasive compared to other methods available. Key players in this field include Medtronic and St Jude Medical known for their high quality occluders and strong reputation, for prioritizing safety in their products.

Transcatheter Asd Occluder vs. Substitutes:
Performance and Positioning Analysis

Transcatheter ASD Occluder stands distinctly as a minimally invasive solution for Atrial Septal Defect closure, offering advantages over traditional open-heart surgeries. This innovation showcases tremendous growth potential in a ever-advancing medical device market

Transcatheter Asd Occluder
  • Amplatzer Septal Occluder /
  • Gore Cardioform Septal Occluder
    Minimally invasive procedure, high success rate, reduced recovery time
    Dependence on accurate diagnosis, potential for residual shunts post-procedure
    Non-invasive procedure, less recovery time needed
    Risk of cardiovascular complications, not suitable for large defects

Transcatheter Asd Occluder vs. Substitutes:
Performance and Positioning Analysis

Transcatheter Asd Occluder

  • Minimally invasive procedure, high success rate, reduced recovery time
  • Dependence on accurate diagnosis, potential for residual shunts post-procedure

Amplatzer Septal Occluder / Gore Cardioform Septal Occluder / Lifetech CeraFlex ASD Occluder

  • Non-invasive procedure, less recovery time needed
  • Risk of cardiovascular complications, not suitable for large defects

Transcatheter ASD Occluder stands distinctly as a minimally invasive solution for Atrial Septal Defect closure, offering advantages over traditional open-heart surgeries. This innovation showcases tremendous growth potential in a ever-advancing medical device market

Loading...

Research Methodology

This market research methodology defines the Transcatheter Asd Occluder market scope, gathers reliable data, and validates findings using integrated primary and secondary research. Our systematic framework ensures precise market sizing, growth trend analysis, and competitive benchmarking.


Secondary Research Approach


We begin secondary research by defining the targeted market at Country and Regional levels. As part of the Medical Device ecosystem, we analyze Transcatheter Asd Occluder across Balloon Expandable, Self-Expandable, and Hybrid Applications. Our team gathers data systematically from country level ministerial sources, industry associations & federations, trade databases, company annual & quarterly reports and other credential sources, enabling us to map global and regional market size, pricing trends, regulatory standards, and technology advancements.


Key Sources Referenced:


We benchmark competitors such as Abbott Laboratories, Boston Scientific Corporation, and Medtronic by reviewing company financial statements, and regulatory filings. Our secondary insights identify key market drivers and constraints, forming the analytical foundation for primary research.


Primary Research Methods


We conduct structured interviews and surveys with industry stakeholders, including Raw Material Suppliers, Component Manufacturers, and Assembly & Testing. Our geographic coverage spans Americas (40%), Europe (30%), Asia-Pacific (25%) and Middle East & Africa (5%). Our online surveys generally achieve a response rate of above 65%, and telephone interviews yield 60%, resulting in above 92% confidence level with a ±7% margin of error.


Through targeted questionnaires and in-depth interviews, we capture purchase intent, adoption barriers, brand perception across Segment Type. We use interview guides to ensure consistency and anonymous survey options to mitigate response bias. These primary insights validate secondary findings and align market sizing with real-world conditions.


Market Engineering & Data Analysis Framework


Our data analysis framework integrates Top-Down, Bottom-Up, and Company Market Share approaches to estimate and project market size with precision.


Top-down & Bottom-Up Process


In Top-down approach, we disaggregate global Medical Device revenues to estimate the Transcatheter Asd Occluder segment, using historical growth patterns to set baseline trends. Simultaneously, in Bottom-up approach, we aggregate Country-Level Demand Data to derive regional and global forecasts, which provide granular consumption insights. By reconciling both approaches, we ensure statistical precision and cross-validation accuracy.


We evaluate the supply chain, spanning Raw Material Suppliers (Johnson & Johnson, Bayer AG), Component Manufacturers (Medtronic, Abbott Laboratories), and Assembly & Testing. Our parallel substitute analysis examines Amplatzer Septal Occluder, Gore Cardioform Septal Occluder, and Lifetech CeraFlex ASD Occluder, highlighting diversification opportunities and competitive risks.


Company Market Share & Benchmarking


We benchmark leading companies such as Abbott Laboratories, Boston Scientific Corporation, and Medtronic, analyzing their capabilities in pricing, product features, technology adoption, and distribution reach. By assessing company-level revenues and product portfolios, we derive market share comparisons, clarifying competitive positioning and growth trajectories across the ecosystem.


Our integration of data triangulation, supply chain evaluation, and company benchmarking, supported by our proprietary Directional Superposition methodology enables us to deliver precise forecasts and actionable strategic insights into the Transcatheter Asd Occluder market.


Quality Assurance and Compliance


We cross-reference secondary data with primary inputs and external expert reviews to confirm consistency. Further, we use stratified sampling, anonymous surveys, third-party interviews, and time-based sampling to reduce bias and strengthen our results.


Our methodology is developed in alignment with ISO 20252 standards and ICC/ESOMAR guidelines for research ethics. The study methodology follows globally recognized frameworks such as ISO 20252 and ICC codes of practice.

rm

Transcatheter Asd Occluder Market Data: Size, Segmentation & Growth Forecast

Report AttributeDetails
Market Value in 2025USD 565 million
Revenue Forecast in 2034USD 1.10 billion
Growth RateCAGR of 7.7% from 2025 to 2034
Base Year for Estimation2024
Industry Revenue 2024524 million
Growth OpportunityUSD 577 million
Historical Data2019 - 2023
Growth Projection / Forecast Period2025 - 2034
Market Size UnitsMarket Revenue in USD million and Industry Statistics
Market Size 2024524 million USD
Market Size 2027655 million USD
Market Size 2029760 million USD
Market Size 2030819 million USD
Market Size 20341.10 billion USD
Market Size 20351.19 billion USD
Report CoverageMarket revenue for past 5 years and forecast for future 10 years, Competitive Analysis & Company Market Share, Strategic Insights & trends
Segments CoveredProduct Type, End-use Industries, Technology, Patient Age, Manufacture Method
Regional scopeNorth America, Europe, Asia Pacific, Latin America and Middle East & Africa
Country scopeU.S., Canada, Mexico, UK, Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Mexico, Argentina, Saudi Arabia, UAE and South Africa
Companies ProfiledAbbott Laboratories, Boston Scientific Corporation, Medtronic, W. L. Gore & Associates, MicroPort Scientific Corporation, Occlutech, Lifetech Scientific, Biotronik, Cook Medical, Visee Medical Devices, St. Jude Medical and Cardia Inc.
CustomizationFree customization at segment, region or country scope and direct contact with report analyst team for 10 to 20 working hours for any additional niche requirement which is almost equivalent to 10% of report value

Explore Report Features and Data Packages

Industry Insight Report

$ 4200
Unlock Multi-User Access for just $999 more
i
No Payment Before Report Delivery
Flexible Payment Options
Additional Features
Customization Available
i
Excel Data Pack Included
Free Analyst Support
i
Industry Expert-Validated Insights
100% Confidentiality Guaranteed
Fast Delivery (24–72 hours)
i
Get Report Now

Strategic Growth Advisory

Unrivaled Custom Market Intelligence & Strategic Advisory for Business Growth and Competitive Excellence

  • Assess and prioritize high-value markets with precision
  • Craft tailored entry and expansion roadmaps
  • De-risk investments through rigorous market intelligence
  • Architect dynamic pricing frameworks aligned to value creation
  • Unlock sustainable margin enhancement opportunities
  • Benchmark performance against global industry leaders
  • Strategically realign portfolios to future growth drivers
  • Accelerate commercialization of breakthrough offerings
  • Harness market foresight and technology shifts to fuel innovation

Discover our Strategic Growth Advisory Services »

Table of Contents

Industry Insights Report - Table Of Contents

Chapter 1

Executive Summary

Major Markets & Their Performance - Statistical Snapshots

Chapter 2

Research Methodology

2.1Axioms & Postulates
2.2Market Introduction & Research MethodologyEstimation & Forecast Parameters / Major Databases & Sources
Chapter 3

Market Dynamics

3.1Market OverviewDrivers / Restraints / Opportunities / M4 Factors
3.2Market Trends
3.2.1Introduction & Narratives
3.2.2Market Trends - Impact Analysis(Short, Medium & Long Term Impacts)
3.3Supply Chain Analysis
3.4Porter's Five ForcesSuppliers & Buyers' Bargaining Power, Threat of Substitution & New Market Entrants, Competitive Rivalry
Chapter 4

Transcatheter Asd Occluder Market Size, Opportunities & Strategic Insights, by Product Type

4.1Balloon Expandable
4.2Self-Expandable
4.3Hybrid
Chapter 5

Transcatheter Asd Occluder Market Size, Opportunities & Strategic Insights, by End-use Industries

5.1Hospitals
5.2Cardiac Centers
5.3Ambulatory Surgical Centers
5.4Others
Chapter 6

Transcatheter Asd Occluder Market Size, Opportunities & Strategic Insights, by Technology

6.1Magnetic Resonance Imaging
6.2Ultrasound-based
Chapter 7

Transcatheter Asd Occluder Market Size, Opportunities & Strategic Insights, by Patient Age

7.1Pediatric
7.2Adult
Chapter 8

Transcatheter Asd Occluder Market Size, Opportunities & Strategic Insights, by Manufacture Method

8.1Automated Production
8.2Manual Production
Chapter 9

Transcatheter Asd Occluder Market, by Region

9.1North America Transcatheter Asd Occluder Market Size, Opportunities, Key Trends & Strategic Insights
9.1.1U.S.
9.1.2Canada
9.2Europe Transcatheter Asd Occluder Market Size, Opportunities, Key Trends & Strategic Insights
9.2.1Germany
9.2.2France
9.2.3UK
9.2.4Italy
9.2.5The Netherlands
9.2.6Rest of EU
9.3Asia Pacific Transcatheter Asd Occluder Market Size, Opportunities, Key Trends & Strategic Insights
9.3.1China
9.3.2Japan
9.3.3South Korea
9.3.4India
9.3.5Australia
9.3.6Thailand
9.3.7Rest of APAC
9.4Middle East & Africa Transcatheter Asd Occluder Market Size, Opportunities, Key Trends & Strategic Insights
9.4.1Saudi Arabia
9.4.2United Arab Emirates
9.4.3South Africa
9.4.4Rest of MEA
9.5Latin America Transcatheter Asd Occluder Market Size, Opportunities, Key Trends & Strategic Insights
9.5.1Brazil
9.5.2Mexico
9.5.3Rest of LA
9.6CIS Transcatheter Asd Occluder Market Size, Opportunities, Key Trends & Strategic Insights
9.6.1Russia
9.6.2Rest of CIS
Chapter 10

Competitive Landscape

10.1Competitive Dashboard & Market Share Analysis
10.2Company Profiles (Overview, Financials, Developments, SWOT)
10.2.1Abbott Laboratories
10.2.2Boston Scientific Corporation
10.2.3Medtronic
10.2.4W. L. Gore & Associates
10.2.5MicroPort Scientific Corporation
10.2.6Occlutech
10.2.7Lifetech Scientific
10.2.8Biotronik
10.2.9Cook Medical
10.2.10Visee Medical Devices
10.2.11St. Jude Medical
10.2.12Cardia Inc.